25 June 2024
25 June 2024
The company’s nitric oxide generator and gas monitoring system, LungFit PH, is expected to generate $2-6m less than the company’s previous guidance of $12-16m.
The funding, led by RH Capital, aims to advance OCONs 3D stent drug delivery frames for the treatment of uterine bleeding.
Following the investment, Illumina now owns a 14.5% stake in Grail.
The system, which is designed to enhance the efficacy of cranial and spinal surgeries, features a single-hand disposable applicator.
The Cordella Pulmonary Artery (PA) Sensor System is intended for treating NYHA class III heart failure patients.
The system allows users to access medical images for diagnostic purposes directly from the cloud.
Having private testing options for the virus may incentivise at-risk individuals to test more frequently.
The software is designed to help clinicians program deep brain stimulation devices for patients living with early stage Parkinson’s disease.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
